Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma

Antonio Omuro, Timothy A. Chan, Lauren E. Abrey, Mustafa Khasraw, Anne S. Reiner, Thomas J. Kaley, Lisa M. DeAngelis, Andrew B. Lassman, Craig P. Nolan, Igor T. Gavrilovic, Adilia Hormigo, Cynthia Salvant, Adriana Heguy, Andrew Kaufman, Jason T. Huse, Katherine S. Panageas, Andreas F. Hottinger, Ingo Mellinghoff

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience